TY - JOUR
T1 - Costo efectividad de los antipsicóticos en el tratamiento de mantenimiento de la esquizofrenia en Colombia
AU - Quitian Reyes, Hoover
AU - Arciniegas Barrera, Jair Alberto
AU - Bohórquez Peñaranda, Adriana
AU - Gómez Restrepo, Carlos
N1 - Publisher Copyright:
© 2014 Asociación Colombiana de Psiquiatría. Published by Elsevier España, S.L.U. All rights reserved.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Objective Assess the cost-effectiveness of the antipsychotics for treatment of schizophrenia. Methods A five-year Markov model was built form patients with schizophrenia on the stage of maintenance. Costs were taken from the perspective of the Colombian health care system (Sistema General de Seguridad Social en Salud). The effectiveness was measured in years of life under the same maintenance plan. Results The Markov model indicated clozapine as the as the most cost-effective alternative between the first line antipsychotics and haloperidol is it when comparing other antipsychotics. Conclusion Clozapine it's the cost-effectiveness strategy among the first line of antipsychotics and haloperidol is it among the other antipsychotics. Strategies prioritizing the use of cost-effective antipsychotics could improve the resources allocation in the Colombian health care system.
AB - Objective Assess the cost-effectiveness of the antipsychotics for treatment of schizophrenia. Methods A five-year Markov model was built form patients with schizophrenia on the stage of maintenance. Costs were taken from the perspective of the Colombian health care system (Sistema General de Seguridad Social en Salud). The effectiveness was measured in years of life under the same maintenance plan. Results The Markov model indicated clozapine as the as the most cost-effective alternative between the first line antipsychotics and haloperidol is it when comparing other antipsychotics. Conclusion Clozapine it's the cost-effectiveness strategy among the first line of antipsychotics and haloperidol is it among the other antipsychotics. Strategies prioritizing the use of cost-effective antipsychotics could improve the resources allocation in the Colombian health care system.
KW - Antipsychotic agents
KW - Cost effectiveness analysis
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=85006200926&partnerID=8YFLogxK
U2 - 10.1016/j.rcp.2015.05.013
DO - 10.1016/j.rcp.2015.05.013
M3 - Artículo
C2 - 27132755
AN - SCOPUS:85006200926
SN - 0034-7450
VL - 45
SP - 67
EP - 74
JO - Revista Colombiana de Psiquiatria
JF - Revista Colombiana de Psiquiatria
IS - 2
ER -